International Stem Cell (ISCO) Shares Outstanding (2010 - 2026)
International Stem Cell (ISCO) posted quarterly Shares Outstanding (Entity) of $8.0 million for Q4 2025, little changed year-over-year from $8.0 million in Q4 2024, and little changed quarter-over-quarter from $8.0 million in Q3 2025.
International Stem Cell (ISCO) Shares Outstanding (2010 - 2026) Analysis & Trends
International Stem Cell (ISCO) has reported Shares Outstanding (Entity) for 16 consecutive years, with $8.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) changed 0.0% year-over-year to $8.0 million; the TTM figure through Dec 2025 stood at $8.0 million (changed 0.0% YoY), while the FY2025 annual figure was $8.0 million, changed 0.0% from the prior year.
- Shares Outstanding (Entity) steadied at $8.0 million in Q4 2025 per ISCO's latest filing, from $8.0 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $16.5 million in Q3 2023 and bottomed at $7.5 million in Q1 2021.
- Historically, Shares Outstanding (Entity) has averaged $8.7 million across 5 years, with a median of $8.0 million in 2021.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) surged 106.5% — and 2024, when it sank 51.57%.
- International Stem Cell's Shares Outstanding (Entity) stood at $8.0 million in 2021, then changed by 0.0% to $8.0 million in 2022, then changed by 0.0% to $8.0 million in 2023, then changed by 0.0% to $8.0 million in 2024, then changed by 0.0% to $8.0 million in 2025.
- Business Quant data shows ISCO's Shares Outstanding (Entity) at $8.0 million in Q4 2025, $8.0 million in Q3 2025, and $8.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 133.61 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 217.35 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 445.06 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 241.70 Mn |
| 10 | International Stem Cell | 4.32 Mn | 3.23 Mn | 1.46 Mn | 8.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.00 Mn |
| Dec 31, 2025 | 8.00 Mn |
| Sep 30, 2025 | 8.00 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 8.00 Mn |
| Mar 31, 2024 | 8.00 Mn |
| Dec 31, 2023 | 8.00 Mn |
| Sep 30, 2023 | 16.53 Mn |
| Jun 30, 2023 | 14.54 Mn |
| Mar 31, 2023 | 8.00 Mn |
| Dec 31, 2022 | 8.00 Mn |
| Sep 30, 2022 | 8.00 Mn |
| Jun 30, 2022 | 8.00 Mn |
| Mar 31, 2022 | 8.00 Mn |
| Dec 31, 2021 | 7.83 Mn |
| Sep 30, 2021 | 8.00 Mn |
| Jun 30, 2021 | 7.77 Mn |